Literature DB >> 18623158

Reconstruction of reflex pathways to the atonic bladder after conus medullaris injury: preliminary clinical results.

Haodong Lin1, Chun-Lin Hou, Guibin Zhong, Qingpin Xie, Shibo Wang.   

Abstract

Neurogenic bladder dysfunction following spinal cord injury is a major medical and social problem for which there is no ideal treatment strategy. In this study, spinal root anastomoses were performed in 10 paraplegic patients with traumatic lesions of the conus medullaris, in an attempt to reinnervate the paralyzed bladder. For the operation, the functional T11 ventral root (VR) above the lesion was transected and anastomosed to the S2 ventral roots unilaterally through a nerve graft. The T11 dorsal root was left intact as the trigger for micturition after axonal regeneration. All patients underwent urodynamic evaluation before surgery and at follow-up. The mean follow-up duration was 2 years. Of the 10 patients, 7 (70%) regained satisfactory bladder control within 18-24 months after VR microanastomosis. In these seven patients, the average bladder capacity decreased from 508 +/- 83 (mean +/- SD) to 370 +/- 59 ml, residual urine decreased from 477 +/- 98 to 35 +/- 11 ml, and urinary infections were not observed. Patients with impaired renal function experienced a full recovery. Three patients failed to show any improvement after the operation. These results suggest that a restitutive process occurs in the bladder following reinnervation from new T11 VR connections to the bladder nerves. Spinal cord lesions that may benefit from such a nerve crossover surgery are those located at the conus, whereby a functional suprasacral nerve can be connected to the sacral roots to bypass the injury in an attempt to restore central connections to the bladder. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18623158     DOI: 10.1002/micr.20504

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  7 in total

1.  Repair, protection and regeneration of spinal cord injury.

Authors: 
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

2.  Reconstruction of atonic bladder innervation after spinal cord injury: A bladder reflex arc with afferent and efferent pathways.

Authors:  Jun He; Guitao Li; Dixin Luo; Hongtao Sun; Yong Qi; Yiyi Li; Xunjie Jin
Journal:  J Spinal Cord Med       Date:  2015-01-13       Impact factor: 1.985

3.  The feasibility study of extradural nerve anastomosis technique for canine bladder reinnervation after spinal cord injury.

Authors:  Jian Tang; Jun Ma; Lei Yang; Xinpeng Huang; Yingbin Ge; Tao Sui; Zhongqing Wei; Xiaojian Cao
Journal:  J Spinal Cord Med       Date:  2016-11       Impact factor: 1.985

4.  Micturition reflex arc reconstruction including sensory and motor nerves after spinal cord injury: urodynamic and electrophysiological responses.

Authors:  Jun Ma; Tao Sui; YuCheng Zhu; AiXiang Zhu; ZhongQing Wei; Xiao Jian Cao
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

5.  Low-frequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency.

Authors:  Dan-Feng Xu; Shen Zhang; Cun-Zhou Wang; Jun Li; Chuang-Yu Qu; Xin-Gang Cui; Sheng-Jia Zhao
Journal:  Int Urogynecol J       Date:  2012-03-23       Impact factor: 2.894

6.  Survey of spinal cord injury-induced neurogenic bladder studies using the Web of Science.

Authors:  Benjing Zou; Yongli Zhang; Yucheng Li; Zantao Wang; Ping Zhang; Xiyin Zhang; Bingdong Wang; Zhixin Long; Feng Wang; Guo Song; Yan Wang
Journal:  Neural Regen Res       Date:  2012-08-15       Impact factor: 5.135

Review 7.  Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).

Authors:  Hongyun Huang; Wise Young; Stephen Skaper; Lin Chen; Gustavo Moviglia; Hooshang Saberi; Ziad Al-Zoubi; Hari Shanker Sharma; Dafin Muresanu; Alok Sharma; Wagih El Masry; Shiqing Feng
Journal:  J Orthop Translat       Date:  2019-11-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.